These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23376242)

  • 1. Liposomes modified with P-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice.
    Hao ZF; Cui YX; Li MH; Du D; Liu MF; Tao HQ; Li S; Cao FY; Chen YL; Lei XH; Wang L; Zhu DL; Peng HS; Jiang CL
    Eur J Pharm Biopharm; 2013 Aug; 84(3):505-16. PubMed ID: 23376242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain.
    Du D; Chang N; Sun S; Li M; Yu H; Liu M; Liu X; Wang G; Li H; Liu X; Geng S; Wang Q; Peng H
    J Control Release; 2014 May; 182():99-110. PubMed ID: 24631863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a promising delivery system in targeting the brain.
    Peng H; Du D; Zhang J
    Ther Deliv; 2013 Dec; 4(12):1475-7. PubMed ID: 24304243
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice.
    Ying X; Wen H; Yao HJ; Zhang Y; Tian W; Zhang L; Ju RJ; Wang XX; Yu Y; Lu WL
    Pharmacology; 2011; 87(1-2):105-14. PubMed ID: 21282968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain.
    Singh I; Swami R; Jeengar MK; Khan W; Sistla R
    Chem Phys Lipids; 2015 May; 188():1-9. PubMed ID: 25819559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.
    Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q
    Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.
    Chono S; Kaneko K; Yamamoto E; Togami K; Morimoto K
    Drug Dev Ind Pharm; 2010 Jan; 36(1):102-7. PubMed ID: 19656002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification.
    Chono S; Tanino T; Seki T; Morimoto K
    J Pharm Pharmacol; 2007 Jan; 59(1):75-80. PubMed ID: 17227623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.
    Chen H; Tang L; Qin Y; Yin Y; Tang J; Tang W; Sun X; Zhang Z; Liu J; He Q
    Eur J Pharm Sci; 2010 May; 40(2):94-102. PubMed ID: 20298779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies.
    Xie Y; Ye L; Zhang X; Cui W; Lou J; Nagai T; Hou X
    J Control Release; 2005 Jun; 105(1-2):106-19. PubMed ID: 15893839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
    Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
    Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes.
    Qin Y; Fan W; Chen H; Yao N; Tang W; Tang J; Yuan W; Kuai R; Zhang Z; Wu Y; He Q
    J Drug Target; 2010 Aug; 18(7):536-49. PubMed ID: 20132091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
    Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
    Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
    Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.
    Kong D; Hong W; Yu M; Li Y; Zheng Y; Ying X
    Int J Nanomedicine; 2022; 17():1087-1110. PubMed ID: 35313461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
    Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
    Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.